Fluoxetine-induced plasticity in the visual cortex outlasts the duration of the naturally occurring critical period

Eur J Neurosci. 2019 Nov;50(10):3663-3673. doi: 10.1111/ejn.14512. Epub 2019 Aug 8.

Abstract

Heightened neuronal plasticity expressed during early postnatal life has been thought to permanently decline once critical periods have ended. For example, monocular deprivation is able to shift ocular dominance in the mouse visual cortex during the first months of life, but this effect is lost later in life. However, various treatments, such as the antidepressant fluoxetine, can reactivate a critical period-like plasticity in the adult brain. When monocular deprivation is supplemented with chronic fluoxetine administration, a major shift in ocular dominance is produced after the critical period has ended. In the current study, we characterized the temporal patterns of fluoxetine-induced plasticity in the adult mouse visual cortex, using in vivo optical imaging. We found that artificially induced plasticity in ocular dominance extended beyond the duration of the naturally occurring critical period and continued as long as fluoxetine was administered. However, this fluoxetine-induced plasticity period ended as soon as the drug was not given. These features of antidepressant-induced plasticity may be useful when designing treatment strategies involving long-term antidepressant treatment in humans.

Keywords: experience-dependent plasticity; mouse brain; neuronal plasticity; optical imaging; visual cortex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology*
  • Female
  • Fluoxetine / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Neuronal Plasticity*
  • Time
  • Visual Cortex / drug effects
  • Visual Cortex / physiology*

Substances

  • Antidepressive Agents
  • Fluoxetine